Global Stem Cell Therapy Market 2024-2028

Global Stem Cell Therapy Market 2024-2028

The stem cell therapy market is forecasted to grow by USD 16677.5 mn during 2023-2028, accelerating at a CAGR of 18.69% during the forecast period. The report on the stem cell therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, increase in awareness of stem cell therapy, and rising regulatory approval for drug development.

Technavio's stem cell therapy market is segmented as below:

By Application

• Cancer
• Musculoskeletal disorder
• Cardiovascular disease
• Others

By Type

• Allogeneic transplants
• Autologous transplants

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the rise in costs of stem cell transplantation as one of the prime reasons driving the stem cell therapy market growth during the next few years. Also, stem cell therapy being potential curative option for chronic diseases and development of ips cells will lead to sizable demand in the market.

The report on the stem cell therapy market covers the following areas:

• Stem cell therapy market sizing
• Stem cell therapy market forecast
• Stem cell therapy market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading stem cell therapy market vendors that include Athersys Inc., Becton Dickinson and Co., Brainstorm Cell Therapeutics Inc., Bristol Myers Squibb Co., CRISPR Therapeutics AG, Cynata Therapeutics Ltd., Cytori Therapeutics Inc., FUJIFILM Corp., Gamida Cell Ltd., Johnson and Johnson Services Inc., Lonza Group Ltd., Mesoblast Ltd., Novartis AG, Pfizer Inc., Pluri Inc., ReNeuron Group plc, STEMCELL Technologies Inc., Takeda Pharmaceutical Co. Ltd., Thermo Fisher Scientific Inc., and Vericel Corp.. Also, the stem cell therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.